Genmab A/S GMAB-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 2:37 PM CET
1,978.50quote price arrow down-43.50 (-2.15%)
Volume
157,012
52 week range
1,951.00 - 2,786.00

...

Loading . . .

KEY STATS

  • Open2,011.00
  • Day High2,016.00
  • Day Low1,951.00
  • Prev Close2,022.00
  • 52 Week High2,786.00
  • 52 Week High Date01/18/21
  • 52 Week Low1,951.00
  • 52 Week Low Date03/04/21
  • Market Cap22,017.05M
  • Shares Out65.41M
  • 10 Day Average Volume269,184.8
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • 1 Year % Change23.92

RATIOS/PROFITABILITY

  • EPS (TTM)73.02
  • P/E (TTM)27.10
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Genmab A/S News

There is no recent news for this security.

Latest GMAB-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment...
Deirdre Connelly
Chairman
Jan van de Winkel Ph.D.
Chief Executive Officer
Anthony Mancini
Chief Operating Officer
Anthony Pagano
Chief Financial Officer
Judith Klimovsky M.D.
Executive Vice President
Marisol Peron
Vice President
Address
Kalvebod Brygge 43
Koebenhavn V
1560
Denmark